Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research
- Written by PR Newswire
![]() |
Collaboration expands access to Lunit's AI-powered pathology platform by combining it with Discovery Life Sciences' global biospecimen and specialty laboratory capabilities, enabling standardized tissue insights for biomarker research and drug development.
SEOUL, South Korea, Oct. 12, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading...














